Vaxcyte Inc Financial Flexibility Index
Vaxcyte Inc financial flexibility index. Vaxcyte Inc (PCVX) has a Financial Flexibility Index of -1.30x as of June 2026. Free cash flow of $-493.73 Million (operating CF $-513.10 Million minus capex $19.37 Million) represents -1% of total liabilities ($380.21 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vaxcyte Inc (2017–2025)
Financial flexibility index of Vaxcyte Inc from 2017 to 2025. Historical Financial Flexibility Index trend for Vaxcyte Inc across 9 annual periods. Explore PCVX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Vaxcyte Inc Financial Flexibility Index by Year (2017–2025)
Vaxcyte Inc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Vaxcyte Inc. For the full cash flow conversion analysis, see PCVX cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.78x | $-641.86 Million | $-655.58 Million | $360.45 Million | ▲ +14.9% |
| 2024 | -2.09x | $-430.20 Million | $-452.63 Million | $205.50 Million | ▼ -53.1% |
| 2023 | -1.37x | $-228.91 Million | $-296.79 Million | $167.45 Million | ▲ +56.4% |
| 2022 | -3.13x | $-164.76 Million | $-170.60 Million | $52.56 Million | ▼ -10.0% |
| 2021 | -2.85x | $-114.84 Million | $-121.39 Million | $40.32 Million | ▼ -194.3% |
| 2020 | -0.97x | $-45.47 Million | $-46.63 Million | $46.98 Million | ▼ -262.4% |
| 2019 | -0.27x | $-45.95 Million | $-47.15 Million | $172.07 Million | ▼ -19.6% |
| 2018 | -0.22x | $-28.69 Million | $-30.47 Million | $128.53 Million | ▼ -14022.4% |
| 2017 | 0.00x | $-13.74K | $-14.96K | $8.69 Million | — |